1. Brown JS, Seeley DG, Fong J, Black DM, Ensrud KE, Grady D. Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol 1996;87(5 Pt 1):715-21.
2. Diokno AC, Brock BM, Herzog AR, Bromberg J. Medical correlates of urinary incontinence in the elderly. Urology 1990;36:129-38.
4. Digesu GA, Khullar V, Cardozo L, Salvatore S. Overactive bladder symptoms: do we need urodynamics? Neurourol Urodyn 2003;22:105-8.
5. Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol 1995;153:342-4.
6. Ueda T, Yoshimura N, Yoshida O. Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol 1997;157:580-4.
7. Robinson D, Anders K, Cardozo L, Bidmead J, Toozs-Hobson P, Khullar V. Can ultrasound replace ambulatory urodynamics when investigating women with irritative urinary symptoms? BJOG 2002;109:145-8.
9. Tanaka H, Matsuda M, Moriya K, Mitsui T, Kitta T, Nonomura K. Ultrasonographic measurement of bladder wall thickness as a risk factor for upper urinary tract deterioration in children with myelodysplasia. J Urol 2008;180:312-6.
10. Pitre DA, Ma T, Wallace LJ, Bauer JA. Time-dependent urinary bladder remodeling in the streptozotocin-induced diabetic rat model. Acta Diabetol 2002;39:23-7.
11. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-80.
13. Tubaro A, Miano L. Managing the consequences of obstruction. Eur Urol Suppl 2002;1:21-7.
14. Uzun H, Zorba OU. Metabolic syndrome in female patients with overactive bladder. Urology 2012;79:72-5.
15. Gallagher EJ, Leroith D, Karnieli E. The metabolic syndrome: from insulin resistance to obesity and diabetes. Med Clin North Am 2011;95:855-73.
16. Azadzoi KM, Chen BG, Radisavljevic ZM, Siroky MB. Molecular reactions and ultrastructural damage in the chronically ischemic bladder. J Urol 2011;186:2115-22.
17. Lee WC, Chien CT, Yu HJ, Lee SW. Bladder dysfunction in rats with metabolic syndrome induced by long-term fructose feeding. J Urol 2008;179:2470-6.
18. Azadzoi KM, Tarcan T, Kozlowski R, Krane RJ, Siroky MB. Over-activity and structural changes in the chronically ischemic bladder. J Urol 1999;162:1768-78.
20. Mónica FZ, Bricola AA, Bau FR, Freitas LL, Teixeira SA, Muscara MN, et al. Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces beta(3)-adrenoceptor-mediated relaxation, causing rat detrusor overactivity. Br J Pharmacol 2008;153:1659-68.
21. Chen Y, Bornfeldt KE, Arner A, Jennische E, Malmqvist U, Uvelius B, et al. Increase in insulin-like growth factor I in hypertrophying smooth muscle. Am J Physiol 1994;266(2 Pt 1):E224-9.
22. Morelli A, Comeglio P, Filippi S, Sarchielli E, Cellai I, Vignozzi L, et al. Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. J Steroid Biochem Mol Biol 2012;132:80-92.